Back to Authors

Luu, Amanda

Mayo Clinic

Mayo Clinic

Citations 1

Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner
Picariello, Hannah S., Kenchappa, Rajappa S., Crish, James F. , Dovas, Athanassios, Pogoda, Katarzyna , McMahon, Mariah, Bell, Emily , Chandrasekharan, Unnikrishnan M. , Luu, Amanda, West, Rita, Canoll, Peter , Odde, David J. , Janmey, Paul A. , Egelhoff, Thomas, Rosenfeld, Steven S. , McMahon, Mariah , Odde, David J , Rai, Vandana, Luu, Amanda, Lammerding, Jan

Proceedings of the National Academy of Sciences | June 25, 2019 | Volume: 116 | Issue: 31 | Pages: 15550-15559

10.1073/pnas.1902847116 Get It

Significance Glioblastoma, the most common and lethal of primary brain tumors, can diffusely infiltrate brain. Because the components of the cytoskeleton that drive tumor invasion are nonredundant, they have been attractive targets for blocking glioblastoma dispersion. However, we find that while targeting one of these—the molecular motor myosin IIA—effectively blocks glioblastoma invasion, it enhances tumor proliferation and lethality. In this study, we have found that myosin IIA functions as a tumor suppressor by reducing signaling of two oncogenes—ERK1/2 and NF-κB—in a manner regulated by the mechanics of the tumor and surrounding brain. Our results also argue that effective treatment of glioblastoma will require inhibiting targets that drive both invasion and proliferation.